19.4 C
New York
Wednesday, June 29, 2022

Axsome Therapeutics Inc (AXSM) Provides Update on Depression Medication AXS-05

Biotech company Axsome Therapeutics Inc (AXSM) has provided an update on AXS-05 for the treatment of depression. The Food and Drug Administration (FDA) notified the company that a review of the depression medication AXS-05 was not completed by its target date of August 22, 2021.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


In spite of this, the FDA did not ask Axsome for additional information, which resulted in a positive reaction in the company’s stock price. AXSM stock soared 14.98% to $24.79 on August 23.

Since last year, AXSM stock has fallen -69.57%, while over the past week, it has gained 16.82%.In the last six months, the stock has dropped by -64.55%, and in the last three months, AXSM stock has lost 54.95 percent. Private investors can purchase shares of Axsome Therapeutics Inc (AXSM) on the SPB Exchange.

As of August 9, the FDA informed Axsome that experts had identified deficiencies in AXS-05, which resulted in a 47% decline in the company’s shares. Axsome Therapeutics Inc (AXSM) replied that it would work to eliminate them, but it informed investors that the timing of the drug’s approval could still be shifted.

Furthermore, Axsome Therapeutics Inc (AXSM) informed investors that its development of other drugs is continuing as normal. Axsome Therapeutics Inc (AXSM) has submitted a submission with the FDA seeking approval for AXS-07, a drug that treats migraines, and will start Phase III trials shortly for AXS-12, a drug that treats insomnia.

There is another drug in the company’s arsenal – AXS-14. This medicine is designed to alleviate muscle, tendon, and joint pain caused by fibromyalgia.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam